CALM2 |
CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca |
UBE3B |
UBE3B: Ubiquitin-protein ligase E3B |
2.777 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
EGFL4 |
MEGF8, C19orf49, EGFL4, KIAA0817: Multiple epidermal growth factor-like domains |
2.777 |
Evidence |
|
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
2.777 |
Evidence |
|
KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
PKD1 |
PKD1: Polycystin-1 precursor |
2.777 |
Evidence |
|
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
2.777 |
Evidence |
|
VAV1 |
VAV1, VAV: Proto-oncogene vav |
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
2.777 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
CAV1 |
CAV1, CAV: Caveolin-1 |
2.777 |
Evidence |
|
CSF2 |
CSF2, GMCSF: Granulocyte-macrophage colony-stimulating factor precursor |
GPR116 |
GPR116, KIAA0758: Probable G-protein coupled receptor 116 precursor |
2.777 |
Evidence |
|
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
2.777 |
Evidence |
|
RGS7 |
RGS7: Regulator of G-protein signaling 7 |
CCR5 |
CCR5: CCR5 receptor (Fragment) |
2.777 |
Evidence |
|
SERPINA5 |
SERPINA5, PCI, PLANH3, PROCI: Plasma serine protease inhibitor precursor |
EGFL4 |
MEGF8, C19orf49, EGFL4, KIAA0817: Multiple epidermal growth factor-like domains |
2.777 |
Evidence |
|
CTLA4 |
CTLA4, CD152: Cytotoxic T-lymphocyte protein 4 precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
2.777 |
Evidence |
|
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
PRKR |
EIF2AK2, PKR, PRKR: Interferon-induced, double-stranded RNA-activated protein ki |
2.775 |
Evidence |
O
|
NPPC |
NPPC, CNP2: C-type natriuretic peptide precursor [Contains: CNP-22; CNP-29; CNP- |
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
2.775 |
Evidence |
|
JAK2 |
JAK2: Tyrosine-protein kinase JAK2 |
CLEC3B |
CLEC3B, TNA: Tetranectin precursor |
2.775 |
Evidence |
|
SGTA |
SGTA, SGT: Small glutamine-rich tetratricopeptide repeat-containing protein A |
AKR1A1 |
AKR1A1, ALDR1, ALR: Alcohol dehydrogenase [NADP+] |
2.772 |
Evidence |
|
RANBP5 |
|
KPNA1 |
KPNA1, RCH2: Importin subunit alpha-1 |
2.77 |
Evidence |
|
HIST1H2BG |
HIST1H2BC, H2BFL, HIST1H2BE, H2BFH, HIST1H2BF, H2BFG, HIST1H2BG, H2BFA, HIST1H2B |
HIST1H3A |
HIST1H3A, H3FA, HIST1H3B, H3FL, HIST1H3C, H3FC, HIST1H3D, H3FB, HIST1H3E, H3FD, |
2.77 |
Evidence |
|
SNRP70 |
SNRP70, RNPU1Z, RPU1, U1AP1: U1 small nuclear ribonucleoprotein 70 kDa |
PABPC3 |
PABPC3, PABP3, PABPL3: Polyadenylate-binding protein 3 |
2.77 |
Evidence |
|
KLF6 |
KLF6, BCD1, COPEB, CPBP, ST12: Krueppel-like factor 6 |
ZNF143 |
ZNF143, SBF: Zinc finger protein 143 |
2.77 |
Evidence |
|
RPA1 |
RPA1, REPA1, RPA70: Replication protein A 70 kDa DNA-binding subunit |
LGP2 |
DHX58, D11LGP2E, LGP2: Probable ATP-dependent RNA helicase DHX58 |
2.77 |
Evidence |
|
HSP90AA1 |
Hsp89-alpha-delta-N |
KIAA0372 |
TTC37, KIAA0372: Tetratricopeptide repeat protein 37 |
2.77 |
Evidence |
|
CSTF2 |
CSTF2: Cleavage stimulation factor 64 kDa subunit |
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
2.77 |
Evidence |
|
USP8 |
USP8, KIAA0055, UBPY: Ubiquitin carboxyl-terminal hydrolase 8 |
USP7 |
USP7, HAUSP: Ubiquitin carboxyl-terminal hydrolase 7 |
2.77 |
Evidence |
|
FOSL1 |
FOSL1, FRA1: Fos-related antigen 1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
2.762 |
Evidence |
|